NFKB1 and acute lymphoblastic leukemia: On the other hand, DNA sequencing confirmed the presence of mutations in NF-κB1, Nrf2, Keap1, and p62 pathways, which disrupt the Nrf2 inhibitory pathway and cause stimulation of this transcription factor in ALL and result in decreased apoptosis in the malignant cell, and chemotherapy resistance.